After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Supernus Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Supernus Pharmaceuticals Inc is $3.09B. A total of 0.9 million shares were traded on the day, compared to an average of 835.04K shares.
In the most recent transaction, Khattar Jack A. sold 59,900 shares of SUPN for 50.57 per share on Oct 09 ’25. After the transaction, the President, CEO now owns 1,206,578 company shares. In a previous transaction on Oct 09 ’25, NEWHALL CHARLES W III sold 25,000 shares at 50.77 per share. SUPN shares that Director owns now total 104,644.
Among the insiders who bought shares, JACK A. KHATTAR acquired of 59,900 shares on Oct 09 ’25 at a per-share price of $48.00. In another insider transaction, CHARLES NEWHALL bought 25,000 shares at $48.00 per share on Oct 09 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SUPN has a high of $57.65 and a low of $29.16.
As of this writing, SUPN has an earnings estimate of $0.82 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $1.52 per share and a lower estimate of $0.33. The company reported an EPS of $1.1 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SUPN’s latest balance sheet shows that the firm has $339.68M in Cash & Short Term Investments as of fiscal 2021. There were $427.03M in debt and $315.38M in liabilities at the time. Its Book Value Per Share was $18.96, while its Total Shareholder’s Equity was $815.85M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SUPN is Buy with a score of 4.71.
